CH680983C1 - - Google Patents
Download PDFInfo
- Publication number
- CH680983C1 CH680983C1 CH2906/90A CH290690A CH680983C1 CH 680983 C1 CH680983 C1 CH 680983C1 CH 2906/90 A CH2906/90 A CH 2906/90A CH 290690 A CH290690 A CH 290690A CH 680983 C1 CH680983 C1 CH 680983C1
- Authority
- CH
- Switzerland
- Prior art keywords
- salmeterol
- inhalation
- sequential
- simultaneous
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898920392A GB8920392D0 (en) | 1989-09-08 | 1989-09-08 | Medicaments |
GB898923644A GB8923644D0 (en) | 1989-10-20 | 1989-10-20 | Medicaments |
SG166294A SG166294G (en) | 1989-09-08 | 1994-11-18 | Inhalation medicaments for treating respiratory disorders |
Publications (3)
Publication Number | Publication Date |
---|---|
CH680983A5 CH680983A5 (fr) | 1992-12-31 |
CH680983C1 true CH680983C1 (fr) | 2008-06-25 |
CH680983C9 CH680983C9 (fr) | 2008-08-15 |
Family
ID=27264677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH2906/90A CH680983C9 (fr) | 1989-09-08 | 1990-09-07 |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0416951B1 (fr) |
JP (1) | JP3042867B2 (fr) |
AT (1) | ATE99941T1 (fr) |
BE (1) | BE1003053A3 (fr) |
CA (1) | CA2024916C (fr) |
CH (1) | CH680983C9 (fr) |
DE (2) | DE69005951T2 (fr) |
DK (1) | DK0416951T3 (fr) |
ES (1) | ES2062392T3 (fr) |
FR (1) | FR2651677B1 (fr) |
HK (1) | HK18695A (fr) |
HU (1) | HU211272A9 (fr) |
IE (1) | IE65535B1 (fr) |
IL (1) | IL95590A (fr) |
IT (1) | IT1241996B (fr) |
LU (1) | LU90392I2 (fr) |
NL (1) | NL990012I2 (fr) |
NZ (1) | NZ235221A (fr) |
PH (1) | PH27594A (fr) |
SG (1) | SG166294G (fr) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270305A (en) | 1989-09-08 | 1993-12-14 | Glaxo Group Limited | Medicaments |
IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
DE69232462T2 (de) * | 1991-12-18 | 2002-10-10 | Astrazeneca Ab, Soedertaelje | Formoterol und budesonide enthaltende zusammensetzung |
SE9703407D0 (sv) | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
NZ511527A (en) | 1998-11-13 | 2002-10-25 | Jago Res A | Dry powder for inhalation |
GB9903759D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
GB9904919D0 (en) | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
EP1143930B8 (fr) | 1999-09-11 | 2008-03-19 | Glaxo Group Limited | Preparation pharmaceutique renfermant du propionate de fluticasone |
AU2206801A (en) * | 1999-12-24 | 2001-07-09 | Alan Leslie Cripps | Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6759398B2 (en) * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
CO5310534A1 (es) * | 2000-08-05 | 2003-08-29 | Glaxo Group Ltd | Nuevos derivados de androstano anti-inflamatorios |
US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
FI20002216A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit astman hoitoon |
FI20002215A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit |
GB0103630D0 (en) * | 2001-02-14 | 2001-03-28 | Glaxo Group Ltd | Chemical compounds |
ATE365720T1 (de) | 2001-03-08 | 2007-07-15 | Glaxo Group Ltd | Agonisten von beta-adrenorezeptoren |
DE60224172T2 (de) | 2001-03-22 | 2008-12-04 | Glaxo Group Ltd., Greenford | Formanilid-derivative als beta2-adrenorezeptor-agonisten |
UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
ES2314052T3 (es) | 2001-04-30 | 2009-03-16 | Glaxo Group Limited | Derivados de ester de 17beta-carbotioato de androstano con un grupo ester ciclico en la posicion 17alfa. |
CA2458534C (fr) | 2001-09-14 | 2011-11-01 | Glaxo Group Limited | Derives de phenethanolamine destines au traitement de maladies respiratoires |
US7258118B2 (en) | 2002-01-24 | 2007-08-21 | Sofotec Gmbh & Co, Kg | Pharmaceutical powder cartridge, and inhaler equipped with same |
DE10202940A1 (de) | 2002-01-24 | 2003-07-31 | Sofotec Gmbh & Co Kg | Patrone für einen Pulverinhalator |
EP1757281A3 (fr) * | 2002-02-04 | 2009-07-15 | Glaxo Group Limited | Formulation pour inhalation comprenant un glucocorticoïde et un agoniste de 2-adrénorécepteur béta |
ATE396716T1 (de) † | 2002-02-04 | 2008-06-15 | Glaxo Group Ltd | Zubereitung zur inhalation enthaltend ein glucocorticoid und einen beta 2-adrenorezeptor agonisten |
WO2003074469A1 (fr) * | 2002-03-04 | 2003-09-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Nouveaux sels d'acide cinnamique, procedes de production et d'utilisation comme medicaments |
GB0208609D0 (en) * | 2002-04-13 | 2002-05-22 | Glaxo Group Ltd | Compositions |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
GB0217225D0 (en) | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicinal compounds |
ATE405275T1 (de) | 2002-12-12 | 2008-09-15 | Nycomed Gmbh | Kombinationsarzneimittel aus r,r-formoterol und ciclesonide |
GB0303396D0 (en) | 2003-02-14 | 2003-03-19 | Glaxo Group Ltd | Medicinal compounds |
SE527069C2 (sv) | 2003-06-19 | 2005-12-13 | Mederio Ag | Förfarande och anordning för administrering av läkemedelspulver |
US20070071689A1 (en) | 2003-08-06 | 2007-03-29 | Galephar M/F | Advantageous combination for inhalation of nacystelyn and bronchodilators |
WO2005087192A2 (fr) * | 2004-03-12 | 2005-09-22 | Cipla Limited | Formulations pour inhalation |
CN1997418B (zh) | 2004-07-16 | 2010-08-11 | 奥米罗有限公司 | 用于粉状药物给药的吸入器,以及用于与该吸入器一起使用的药粉筒系统 |
RU2456027C2 (ru) | 2006-12-22 | 2012-07-20 | Альмираль, С.А. | Ингаляционное устройство для медикаментов в порошковой форме |
CN101744792B (zh) * | 2008-12-17 | 2013-04-17 | 张凯 | 氟替卡松丙酸酯和沙美特罗昔萘酸酯复方干粉吸入剂及其制备工艺 |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
LT2435025T (lt) | 2009-05-29 | 2016-09-26 | Pearl Therapeutics, Inc. | Veikliosios medžiagos tiekimas per kvėpavimo takus |
KR102391332B1 (ko) | 2013-03-15 | 2022-04-26 | 펄 테라퓨틱스 인코포레이티드 | 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템 |
EP2991625A1 (fr) * | 2013-04-29 | 2016-03-09 | Sanofi SA | Compositions pharmaceutiques inhalables et dispositifs inhalateurs contenant ces compositions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2107715B (en) * | 1981-10-19 | 1985-11-13 | Glaxo Group Ltd | Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it |
ZW6584A1 (en) * | 1983-04-18 | 1985-04-17 | Glaxo Group Ltd | Phenethanolamine derivatives |
FR2588474B1 (fr) * | 1985-10-16 | 1987-11-27 | Cird | Compositions synergetiques anti-inflammatoires a base d'un corticosteroide et d'un beta agoniste |
-
1990
- 1990-09-05 IL IL9559090A patent/IL95590A/en not_active IP Right Cessation
- 1990-09-07 JP JP2235997A patent/JP3042867B2/ja not_active Expired - Lifetime
- 1990-09-07 ES ES90309846T patent/ES2062392T3/es not_active Expired - Lifetime
- 1990-09-07 PH PH41153A patent/PH27594A/en unknown
- 1990-09-07 IE IE325690A patent/IE65535B1/en not_active IP Right Cessation
- 1990-09-07 NZ NZ235221A patent/NZ235221A/en unknown
- 1990-09-07 IT IT48260A patent/IT1241996B/it active Protection Beyond IP Right Term
- 1990-09-07 FR FR909011142A patent/FR2651677B1/fr not_active Expired - Lifetime
- 1990-09-07 DE DE69005951T patent/DE69005951T2/de not_active Expired - Lifetime
- 1990-09-07 EP EP90309846A patent/EP0416951B1/fr not_active Expired - Lifetime
- 1990-09-07 DE DE1990605951 patent/DE19975040I2/de active Active
- 1990-09-07 DK DK90309846.5T patent/DK0416951T3/da active
- 1990-09-07 CA CA002024916A patent/CA2024916C/fr not_active Expired - Lifetime
- 1990-09-07 CH CH2906/90A patent/CH680983C9/de not_active IP Right Cessation
- 1990-09-07 BE BE9000862A patent/BE1003053A3/fr not_active IP Right Cessation
- 1990-09-07 AT AT90309846T patent/ATE99941T1/de active
-
1994
- 1994-11-18 SG SG166294A patent/SG166294G/en unknown
-
1995
- 1995-02-09 HK HK18695A patent/HK18695A/xx not_active IP Right Cessation
- 1995-06-02 HU HU95P/P00150P patent/HU211272A9/hu unknown
-
1999
- 1999-04-14 NL NL990012C patent/NL990012I2/nl unknown
- 1999-04-26 LU LU90392C patent/LU90392I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
DE19975040I2 (de) | 2006-07-13 |
EP0416951B1 (fr) | 1994-01-12 |
ES2062392T3 (es) | 1994-12-16 |
IT9048260A1 (it) | 1992-03-07 |
FR2651677A1 (fr) | 1991-03-15 |
HU211272A9 (en) | 1995-11-28 |
IL95590A0 (en) | 1991-09-16 |
FR2651677B1 (fr) | 1993-08-06 |
EP0416951A1 (fr) | 1991-03-13 |
IT1241996B (it) | 1994-02-02 |
IE65535B1 (en) | 1995-11-01 |
LU90392I2 (fr) | 1999-06-28 |
DK0416951T3 (da) | 1994-02-14 |
CH680983C9 (fr) | 2008-08-15 |
SG166294G (en) | 1995-06-16 |
CH680983A5 (fr) | 1992-12-31 |
DE69005951D1 (de) | 1994-02-24 |
CA2024916A1 (fr) | 1991-03-09 |
ATE99941T1 (de) | 1994-01-15 |
IT9048260A0 (it) | 1990-09-07 |
PH27594A (en) | 1993-08-31 |
NL990012I1 (nl) | 1999-07-01 |
IL95590A (en) | 1996-06-18 |
HK18695A (en) | 1995-02-17 |
NL990012I2 (nl) | 1999-09-01 |
JP3042867B2 (ja) | 2000-05-22 |
DE69005951T2 (de) | 1994-05-26 |
NZ235221A (en) | 1992-11-25 |
JPH03167120A (ja) | 1991-07-19 |
CA2024916C (fr) | 2002-07-09 |
BE1003053A3 (fr) | 1991-11-05 |
IE903256A1 (en) | 1991-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH680983C9 (fr) | ||
GB2235626B (en) | Inhalation medicaments for treating respiratory disorders | |
CA2123909A1 (fr) | Nouvelle combinaison de formoterol et de budesonide | |
CA2093806A1 (fr) | Methode de traitement ou de prevention du diabete de type 1 par l'administration orale d'insuline | |
GR3032374T3 (en) | Pharmaceutical compositions for systemic administration of erythropoietin via the respiratory system. | |
GEP20002253B (en) | Pharmaceutical Aerosol Formulation, Proportioning Inhalator and Method for Treatment of Respiratory Diseases | |
GB9425160D0 (en) | Medicaments | |
ATE515265T1 (de) | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen | |
GB8623557D0 (en) | Therapeutic agents | |
GR3015014T3 (en) | Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts. | |
MY111155A (en) | Medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCF | Supplementary protection certificate filed |
Free format text: OICM-NO 54975/19990329, 19990602 |
|
SPCG | Supplementary protection certificate granted |
Free format text: OICM-NO 54975/19990329, 19990602, EXPIRES:20140329 |
|
SPCN | Certificates - modification new representative |
Spc suppl protection certif: C680983/01 Representative=s name: BRAUNPAT BRAUN EDER AG, CH |
|
NV | New agent | ||
PFA | Name/firm changed |
Owner name: GLAXO GROUP LIMITED Free format text: GLAXO GROUP LIMITED#6-12 CLARGES STREET#LONDON W1Y 8DH (GB) $ ISLER & PEDRAZZINI AG#POSTFACH 1772#8027 ZUERICH (CH) -TRANSFER TO- GLAXO GROUP LIMITED#GLAXO WELLCOME HOUSE, BERKELEY AVENUE#GREENFORD (MIDDX UB6 0NN) (GB) $ ISLER & PEDRAZZINI AG#POSTFACH 1772#8027 ZUERICH (CH) |
|
PK | Correction |
Free format text: LE MANDATAIRE A ETE MENTIONNE PAR ERREUR COMME TITULAIRE. |
|
AEN | Scope or validity of the patent modified |
Free format text: DECLARATION DE RENONCIATION PUBLIEE: 25.06.2008 |
|
PK | Correction |
Free format text: INHABER + VERTRETER KORRIGIERT. |
|
PL | Patent ceased | ||
SPCP | Certificates - modification of firm |
Owner name: GLAXO GROUP LIMITED, GB Spc suppl protection certif: C680983/01 |
|
SPCL | Supplementary protection certificate deletion |
Spc suppl protection certif: C680983/01 |